Jul 19, 2018
Pierre Laurin, B.Sc.Pharm., M.Sc is President and CEO, Prometic Life Sciences, a company working to address varying forms of fibrosis. Pierre points out how much researchers have learned about fibrosis just over the last 10 years and how it is more common than you may think attacking vital organs for a variety of reasons. We also learn about what Prometic is doing to tackle highly progressive fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and the ultra-rare condition Alström syndrome.
#fibrosis #ipf #alstromsyndrome